scispace - formally typeset
B

Béatrice Cambien

Researcher at University of Nice Sophia Antipolis

Publications -  30
Citations -  1822

Béatrice Cambien is an academic researcher from University of Nice Sophia Antipolis. The author has contributed to research in topics: Genetic enhancement & Cancer. The author has an hindex of 15, co-authored 30 publications receiving 1690 citations. Previous affiliations of Béatrice Cambien include French Institute of Health and Medical Research & Commissariat à l'énergie atomique et aux énergies alternatives.

Papers
More filters
Journal ArticleDOI

Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor

TL;DR: It is shown that NO inhibits exocytosis of Weibel-Palade bodies, endothelial granules that mediate vascular inflammation and thrombosis, by regulating the activity of N-ethylmaleimide-sensitive factor (NSF).
Journal ArticleDOI

Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

TL;DR: P-sel–Ig treatment could become a new approach to sustained control of bleeding in hemophilia by inducing formation of procoagulant microparticles in human blood through P-selectin glycoprotein ligand-1 (PSGL-1; encoded by the Psgl1 gene, officially known as Selpl).
Journal ArticleDOI

Signal transduction involved in MCP-1–mediated monocytic transendothelial migration

TL;DR: Coordinated action of distinct signal pathways is required to produce a full response to MCP-1 in terms of monocytic locomotion, and the results underscore the major implication of Go/Gi proteins and nonreceptor tyrosine kinases in the early MCP
Journal ArticleDOI

A new role in hemostasis for the adhesion receptor P-selectin.

TL;DR: The adhesion receptor P-selectin has long been known to support leukocyte rolling and emigration at sites of inflammation, and recent developments suggest that the procoagulant potential of P- selectin could be used to treat coagulation disorders such as hemophilia A.